Unknown

Dataset Information

Propoxyphene and the risk of out-of-hospital death.


ABSTRACT:

Purpose

The opioid analgesic propoxyphene was withdrawn from the US market in 2010, motivated by concerns regarding fatality in overdose and adverse cardiac effects, including prolongation of the QT interval. These concerns were based on case reports, summary vital statistics, and surrogate endpoint studies.

Methods

Using the linked Tennessee Medicaid database (1992-2007), we conducted a retrospective cohort study that compared risk of sudden cardiac, medication toxicity, and total out-of-hospital death for propoxyphene users with that for comparable nonusers of any prescribed opioid analgesic and users of hydrocodone, an opioid with similar indications. Cohort members had 1,873,500 propoxyphene prescriptions, 1,873,500 matched nonuser control periods, and 936,750 matched hy

SUBMITTER: Ray WA 

PROVIDER: S-EPMC3694329 | biostudies-literature | 2013 Apr

REPOSITORIES: biostudies-literature